Fresenius rises after co ups outlook, reports Q2 adj. EBIT beat
BUZZ-Fresenius rises after co ups outlook, reports Q2 adj. EBIT beat ** German healthcare group Fresenius's FREG.DE stock rises 3.5% in early Frankfurt trade after it raised core EPS growth guidance for 2026 and reported a better-than-expected earnings before interests, taxes and special effects
** Fresenius said it expects adjusted core earnings per share to grow by 10-15% in 2026, having previously guided for 5-10%
** Q2 adjusted earnings before interest, taxes and special effects were €719 million ($829 million), above a Vara consensus of €693.1 million.
** "Fresenius delivered a strong Q2," Jefferies summed up in a note following the results
** Fresenius is among the top performers of the German blue-chip index .GDAXI in early Frankfurt trade
($1 = 0.8669 euros)
(Reporting by Tristan Veyet)
Recent news on Fresenius SE & Co. KGaA
See all newsFresenius lifts 2026 expectations after strong Q3 (updated)
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Brief: Fresenius SE Q3 Revenue EUR 5,803 Million
Fresenius signs biosimilars pipeline agreement with WuXi Biologics (updated)